简介:目的探讨复杂性视网膜脱离术后疼痛与舒适护理对策。方法选取我院于2015年9月-2016年6月行复杂性视网膜脱离术的136例视网膜患者的临床资料,按照随机盲选的方式进行分组,分别为观察组和对照组,两组各有68例患者,采用视觉模拟评分法对患者术后的疼痛程度及疼痛原因进行评估,并选择恰当的护理对策。结果对照组患者术后疼痛发生率为58例,轻度、中度、重度疼痛级别分别为43例、10例、5例;观察组患者术后疼痛发生率为42例,轻度、中度、重度疼痛级别分别为16例、20例、6例,对照组患者的术后疼痛程度明显高于观察组患者,两组术后疼痛及疼痛程度对比,差异具有统计学意义(P〈0.05)。结论减轻患者术后疼痛,在使裂孔处于最高位的基础上,对体位的适当调整,能够提高患者术后舒适程度。
简介:目的探讨前列腺素类药结合玻璃体腔注射雷珠单抗治疗新生血管性青光眼的效果。方法伴发高眼压的新生血管性青光眼患者160例根据随机数字表法分为治疗组80例与对照组80例,两组都给予复合式小梁切除术,对照组选择拉坦前列腺素辅助治疗,治疗组选择拉坦前列腺素联合玻璃体腔注射雷珠单抗辅助治疗。结果治疗后治疗组与对照组的治疗有效率分别为97.5%和88.8%,治疗组的治疗有效率明显高于对照组(P〈0.05)。两组治疗后最佳矫正视力都明显提高,而眼压都明显下降,与治疗前对比差异明显(P〈0.05);同时治疗后治疗组的最佳矫正视力与眼压也都明显好于对照组(P〈0.05)。治疗期间治疗组的眼结膜充血、前房炎症反应、角膜水肿、一过性视觉模糊等并发症发生率都明显低于对照组(P〈0.05)。所有患者治疗后随访调查6个月,治疗组的治疗后3个月与6个月的复发率分别为1.3%和5.0%,而对照组分别为7.5%和13.8%,治疗组治疗后3个月与6个月的复发率明显少于对照组(P〈0.05)。结论前列腺素类药结合玻璃体腔注射雷珠单抗治疗新生血管性青光眼能促进眼压的降低,改善视力水平,安全性好,降低复发,从而有利于近远期疗效的提高。
简介:目的探讨微小型甲状腺乳头状癌颈淋巴转移的临床意义.方法回顾性分析1998年5月~2001年12月住院治疗的27例微小型甲状腺乳头状癌患者,其中23例行颈清扫术,并与同期住院治疗的144例非微小型甲状腺乳头状癌进行对比.结果微小型与非微小型甲状腺乳头状癌颈部淋巴结转移分别为12/23(52.2%)、108/144(75.0%),淋巴结阳性率分别为29.7%、37.8%;Ⅵ区淋巴结转移分别为9/23(39.1%)、43/58(74.1%),淋巴结阳性率分别为32.0%、58.4%;Ⅰ-Ⅴ区淋巴结转移分别为11/23(47.8%)、93/144(64.6%),淋巴结阳性率分别为15.2%、34.9%,三者统计学均有显著性意义.10例临床颈部N0微小型甲状腺乳头状癌患者,6例病理检查发现淋巴结转移.结论微小型甲状腺乳头状癌患者颈淋巴结转移比非微小型低,以颈静脉链为常见部位,其次是气管食管沟.对一个确诊为微小型甲状腺乳头状癌患者,都应行颈清扫术.
简介:目的观察曲伏前列素滴眼液用于超声乳化白内障吸除术后的残余慢性闭角型青光眼的降眼压效果。方法回顾性观察超声乳化术后眼压控制不满意的慢性闭角型青光眼15例(15只眼)。测量日眼压曲线后给予每晚1次0.004%曲伏前列素滴眼液滴眼。分别于用药1周、4周、8周时测量日眼压曲线,比较用药前后的眼压峰值及眼压波动幅度。结果用药前平均眼压峰值(23.83±3.74)mmHg(1mmHg=0.133kPa),用药1周后眼压峰值平均为(15.25±3.71)mmHg,眼压下降幅度36.0%,眼压峰值下降明显,差异有统计学意义(P〈0.01)。用药后1周眼压波动幅度下降,差异有统计学意义(P〈0.01)。用药后眼压控制平稳,未见全身及局部严重不良反应。结论曲伏前列素滴眼液是治疗超声乳化术后残余慢性闭角型青光眼的安全、有效药物。(中国眼耳鼻喉科杂志,2010,10:227-228)
简介:AIM:Toinvestigatewhether15-Lipoxygenase-1(15-LOX-1)playsanimportantroleintheregulationofangiogenesis,inhibitinghypoxia-inducedproliferationofretinalmicrovascularendothelialcells(RMVECs)andtheunderlyingmechanism.METHODS:PrimaryRMVECswereisolatedfromtheretinasofC57/BL6JmiceandidentifiedbyanevaluationforFITC-markedCD31.ThehypoxiamodelswereestablishedwiththeBio-bagandevaluatedwithablood-gasanalyzer.ExperimentswereperformedusingRMVECstreatedwithandwithouttransferAd-15-LOX-1orAd-vectorbothunderhypoxiaandnormoxiaconditionat12,24,48,72hours.Theefficacyofthegenetransferwasassessedbyimmunofluorescencestaining.CellsproliferationwasevaluatedbytheCCK-8method.RNAandproteinexpressionsof15-LOX-1,VEGF-A,VEGFR-2,eNOsandPPAR-rwereanalyzedbyreal-timereversetranscriptionpolymerasechainreaction(RT-PCR)andWesternblot.RESULTS:RoutineevaluationforFITC-markedCD31showedthatcellswerepure.Theresultsofblood-gasanalysisshowedthatwhenthecultureswereexposedtohypoxiaformorethan2hours,thePo2was4.5to5.4Kpa.WeverifiedRMVECscouldbeinfectedwithAd-15-LOX-1orAd-vectorviaFluorescencemicroscopy.CCK-8analysisrevealedthattheproliferativecapacitiesofRMVECsinhypoxicgroupweresignificantlyhigherateachtimepointthantheywereinnormoxicgroup(P<0.05).Inahypoxiccondition,theproliferativecapacitiesofRMVECsin15-LOX-1groupweresignificantlyinhibited(P<0.05).Real-timeRT-PCRanalysisrevealedthattheexpressionsofVEGF-A,VEGF-R2andeNOsmRNAincreasedinhypoxiagroupcomparedwithnormoxiagroup(P<0.01).However,theexpressionsof15-LOX-1,PPAR-rmRNAdecreasedinhypoxiagroupcomparedwithnormoxiagroup(P<0.01).Italsoshowedthatinahypoxiccondition,theexpressionsofVEGF-A,VEGF-R2andeNOsmRNAdecreasedsignificantlyin15-LOX-1groupcomparedwithhypoxiagroup(P<0.01).However,15-LOX-1andPPAR-rmRNAincreasedsigni
简介:AIM:Todescribethecharacteristicsofmodulationtransferfunction(MTF)ofanteriorcornealsurface,andobtainthethenormalreferencerangeofMTFatdifferentspatialfrequenciesandopticalzonesoftheanteriorcornealsurfaceinmyopes.·METHODS:Fourhundredeyesfrom200patientswereexaminedunderSIRIUScornealtopographysystem.PhoenisanalysissoftwarewasappliedtosimulatetheMTFcurvesofanteriorcornealsurfaceatverticalandhorizontalmeridiansatthe3,4,5,6,7mmopticalzonesofcornea.TheMTFvaluesatspatialfrequenciesof5,10,15,20,25,30,35,40,45,50,55and60cycles/degree(c/d)wereselected.·RESULTS:TheMTFcurveofanteriorcornealsurfacedecreasedrapidlyfromlowtointermediatefrequency(0-15cpd)atvariousopticalzonesofcornea,thevaluedecreasedto0slowlyathigherfrequency(>15cpd).Withtheincreaseoftheopticalzonesofcornea,MTFcurvedecreasedgradually.3)Intherangeof3mm-6mmopticalzonesofthecornea,theMTFvaluesmeasuredathorizontalmeridianweregreaterthanthecorrespondingvaluesathorizontalmeridianofeachspatialfrequency,thedifferencewasstatisticallysignificant(P<0.05).At7mmopticalzonesofcornea,theMTFvaluesmeasuredathorizontalmeridianwerelessthanthecorrespondingvaluesatverticalmeridianat10-60spatialfrequencies(cpd),andthedifferencewasstatisticallysignificantin25,30,35,40,45,50cpd(P<0.05).·CONCLUSION:MTFcanbeusedtodescribetheimagingqualityofopticalsystemsatanteriorcornealsurfaceobjectivelyindetail.
简介:目的:系统评价拉坦前列素(Latanoprost)滴眼液与噻吗心安(Timolol)滴眼液降眼压的有效性和安全性。方法:计算机检索PubMed,Medline,CNKI及中国生物医学文献数据库收录的,并辅以手工检索、因特网搜索的有关拉坦前列素与噻吗心安治疗原发性开角型青光眼和高眼压症的随机对照试验(RCT)。按照纳入和排除标准限定研究对象,通过Jadad评分量表进行文献质量评估后,针对眼压下降比例、药物不良反应2项内容,使用Cochrane协作网提供的RevMan5.0软件进行Meta分析。结果:共纳入9项RCT,合计555例患者。Meta分析结果显示:(1)拉坦前列素滴眼液与噻吗心安滴眼液降眼压效果,在2,6,12wk时差异均有统计学意义(P<0.01),加权平均差(WMD)分别为:在2wk[WMD=-0.76,95%CI(-1.32,-0.20)],在6wk[WMD=-1.15,95%CI(-1.68,0.63)]和12wk[WMD=-1.01,95%CI(-1.42,-0.61)]。(2)随访结束时,结膜充血、异物感为拉坦前列素的两种较为常见的不良反应,但其发生率拉坦前列素组与噻吗心安组比较,结膜充血的发生率[OR=2.25,95%CI(0.99,5.08)],异物感的发生率[OR=2.48,95%CI(1.02,6.03)],显示二者差异均无统计学意义。结论:治疗原发性开角型青光眼和高眼压症,拉坦前列素降眼压效果在用药12wk内较噻吗心安好;两者在12wk内引起结膜充血、异物感、虹膜色素加深、视野损害等的不良反应方面,差异不明显。由于纳入研究的样本量偏小,且方法学质量中等,致使本系统评价结果论证强度不高,因此还需要开展更多的高质量的临床随机对照研究,以便更客观、准确、全面地评价其疗效和安全性。
简介:AIM:Toinvestigatethespecialtyoftranscranialsurgerythroughpterionalapproachforremovalofcranio-orbitaltumors,introducetheophthalmologicalexperiencesofenteringtheorbittoreducetheincidencerateofassociatedcomplicationsofthisoperation.·METHODS:Weperformedaretrospectiveanalysisofaseriesof37casesinvolvingpatientswhounderwenttranscranialsurgerythroughpterionalapproachfortreatmentofcranio-orbitaltumorsinourdepartmentinthepast8years.Pterionapproachcraniotomywasperformedtoallpatients.Afterremovingtumorsintheskullbytheneurosurgeon,ophthalmologistremovedtumorsinorbit.Wetookmeasuresbelowtodecreasecomplications,includinggroundingopticcanalthroughanabrasivedrillingwhennecessary,hangingvariousextraocularmusclestobeexposedforprotection,refrigeratingbyrefrigerationheadstoremovetumors,atlastsewinguporbitseptumaftersurgery.·RESULTS:Tumorswereremovedcompletelyin32cases,andincompletein5casesduetoextensiveinvasionintothecavernoussinusorsphenoidsinus.Ofallthecases,benigntumorsweredemonstratedin28cases(75.6%,28/37)andmalignantin9(24.3%,9/37).Themostcommonlesiontypewasmeningiomain11cases(29.7%,11/37).Extraocularmuscles(EOM)impairment,occurringin21cases(56.7%,21/37),wasthemostfrequentpostoperativecomplication.Themostseriousconsequencewasvisionlossoccurredin4cases(10.8%,4/37).Othercomplications,suchas11casesoftransientblepharoptosis29.7%(11/37),5casesofmydriasisin13.5%(5/7);2casesofcerebrospinalrhinorrheain5.4%(2/37).·CONCLUSION:Cranio-orbitaltumorscanberemovedcompletelyusingtranscranialapproach,andthepterionalapproachoffersexcellentexposure.Cooperationofinterdisciplinaryteamofneurosurgeonsandophthalmologistsconducestofulluseofrespectiveprofessionaladvantages.Theexperienceofophthalmicoperationtechnologycandecreaseoccurrenceofocularcomplicationsaftersurger